Mauro Magnani

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini et al. · British Journal of Cancer · 2009 · 561 citations · Full text

Medicine, Genetics, Oncology +17

PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

Fotios Loupakis, Luca Emanuele Pollina, I. Stasi et al. · Journal of Clinical Oncology · 2009 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells

Vilberto Stocchi, Luigi Cucchiarini, Mauro Magnani et al. · Analytical Biochemistry · 1985 · 349 citations

Pharmacy, Biochemistry, Hematology +15

Development of a Real-Time PCR Assay for Rapid Detection and Quantification of<i>Alexandrium minutum</i>(a Dinoflagellate)

Luca Galluzzi, Antonella Penna, Elena Bertozzini et al. · Applied and Environmental Microbiology · 2004 · 276 citations · Full text

Life Sciences, Marine Biology, Marine Sciences +16

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis et al. · Journal of Clinical Oncology · 2007 · 266 citations · Full text

Medicine, Oncology, Pharmacology +17